Answers are grounded in this paper and cite their sources.
Analysis suggests MME modulation may improve outcomes in diabetic nephropathy, indicating new treatment strategies.
This study suggests that NGR1 may exert renoprotective effects in DN potentially through MME modulation, which appears to mitigate oxidative stress, inflammation, and fibrosis. The findings indicate MME could serve as a promising therapeutic target, providing preliminary mechanistic insights for developing targeted DN therapies.
No takes yet. Share an insight, caveat, or question.
Gan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: